Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Rodrigo Martino et al.|Experimental Hematology and Oncology|2020Cited by 159
Conventional versus reduced‐intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignanciesDavid Valcárcel, Jorge Sierra, Rodrigo Martino et al.|European Journal Of Haematology|2005Cited by 66
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCTRodrigo Martino, Jorge Sierra, José Luís Piñana et al.|Bone Marrow Transplantation|2009Cited by 59
Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategyMauricio Sarmiento, Anna Sureda, Pablo Ramírez et al.|Bone Marrow Transplantation|2018Cited by 52
Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?Jesús Fernández‐Sojo, Sergio Querol, Cristina Díaz de Heredia et al.|Bone Marrow Transplantation|2021Cited by 24